Detalhe da pesquisa
1.
A systematic review and meta-analysis of beta-blockers and renin-angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer.
Eur Heart J
; 43(27): 2562-2569, 2022 07 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34951629